Paper39711784
Unravelling the mechanisms causing murepavadin resistance in Pseudomonas aeruginosa: lipopolysaccharide alterations and its consequences.
Hernández-García M and 15 others. Front Cell Infect Microbiol, 2024. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Unravelling the mechanisms causing murepavadin resistance in Pseudomonas aeruginosa: lipopolysaccharide alterations and its consequences. Papers, record 39711784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39711784
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Unravelling the mechanisms causing murepavadin resistance in Pseudomonas aeruginosa: lipopolysaccharide alterations and its consequences.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pseudomonas aeruginosa | Major topic |
| Microbial Sensitivity Tests | Major topic |
| Drug Resistance, Bacterial | Major topic |
| Lipopolysaccharides | Major topic |
| Lipid A | Major topic |
| Anti-Bacterial Agents | Major topic |
| Colistin | Major topic |
| Genome-Wide Association Study | Major topic |
| Bacterial Proteins | Major topic |
| Humans | |
| Pseudomonas Infections | |
| Antimicrobial Cationic Peptides | |
| Cathelicidins | |
| Mutation | |
| Acyltransferases | |
| Peptides, Cyclic |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31849667 | Snake Venom Cathelicidins as Natural Antimicrobial Peptides. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31849667 | PubMed |
| 2 | 16998183 | Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites. | Nucleic Acids Res | 2006 | https://conductscience.org/library/papers/16998183 | PubMed |
| 3 | 29451043 | Murepavadin: a new antibiotic class in the pipeline. | Expert Rev Anti Infect Ther | 2018 | https://conductscience.org/library/papers/29451043 | PubMed |
| 4 | 19752280 | Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19752280 | PubMed |
| 5 | 29359918 | A Peptidomimetic Antibiotic Interacts with the Periplasmic Domain of LptD from Pseudomonas aeruginosa. | ACS Chem Biol | 2018 | https://conductscience.org/library/papers/29359918 | PubMed |
| 6 | 26223882 | Site-specific activity of the acyltransferases HtrB1 and HtrB2 in Pseudomonas aeruginosa lipid A biosynthesis. | Pathog Dis | 2015 | https://conductscience.org/library/papers/26223882 | PubMed |
| 7 | 25846400 | Extracellular zinc induces phosphoethanolamine addition to Pseudomonas aeruginosa lipid A via the ColRS two-component system. | Mol Microbiol | 2015 | https://conductscience.org/library/papers/25846400 | PubMed |
| 8 | 18556795 | Induction by cationic antimicrobial peptides and involvement in intrinsic polymyxin and antimicrobial peptide resistance, biofilm formation, and swarming motility of PsrA in Pseudomonas aeruginosa. | J Bacteriol | 2008 | https://conductscience.org/library/papers/18556795 | PubMed |
| 9 | 24065161 | Influence of lipid A acylation pattern on membrane permeability and innate immune stimulation. | Mar Drugs | 2013 | https://conductscience.org/library/papers/24065161 | PubMed |
| 10 | 36290075 | Antimicrobial Peptides-Mechanisms of Action, Antimicrobial Effects and Clinical Applications. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36290075 | PubMed |
| 11 | 30442491 | Pseudomonas aeruginosa colonization causes PD-L1 overexpression on monocytes, impairing the adaptive immune response in patients with cystic fibrosis. | J Cyst Fibros | 2019 | https://conductscience.org/library/papers/30442491 | PubMed |
| 12 | 31383668 | Production of Norspermidine Contributes to Aminoglycoside Resistance in pmrAB Mutants of Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31383668 | PubMed |
| 13 | 16352835 | The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway. | J Bacteriol | 2006 | https://conductscience.org/library/papers/16352835 | PubMed |
| 14 | 34248979 | Murepavadin, a Small Molecule Host Defense Peptide Mimetic, Activates Mast Cells via MRGPRX2 and MrgprB2. | Front Immunol | 2021 | https://conductscience.org/library/papers/34248979 | PubMed |
| 15 | 35350118 | Realistic and critical review of the state of systemic antimicrobial peptides. | ADMET DMPK | 2022 | https://conductscience.org/library/papers/35350118 | PubMed |
| 16 | 26345428 | On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death. | Integr Biol (Camb) | 2015 | https://conductscience.org/library/papers/26345428 | PubMed |
| 17 | 35018535 | Indolicidin revisited: biological activity, potential applications and perspectives of an antimicrobial peptide not yet fully explored. | World J Microbiol Biotechnol | 2022 | https://conductscience.org/library/papers/35018535 | PubMed |
| 18 | 17763333 | Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis. | J Infect Dis | 2007 | https://conductscience.org/library/papers/17763333 | PubMed |
| 19 | 32100713 | Benchmarking bacterial genome-wide association study methods using simulated genomes and phenotypes. | Microb Genom | 2020 | https://conductscience.org/library/papers/32100713 | PubMed |
| 20 | 14620153 | Cathelicidins and innate defense against invasive bacterial infection. | Scand J Infect Dis | 2003 | https://conductscience.org/library/papers/14620153 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42750372 | Peptide-Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42750372 | PubMed |
| 42388494 | Bacterial mutation dynamics emerging insights into virulence evolution and drug resistance. A review study. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42388494 | PubMed |
| 42306526 | Engineering low-endotoxin lipid A in a double auxotroph Pseudomonas aeruginosa to develop safer whole-cell vaccines. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42306526 | PubMed |
| 41901741 | Glnk Mediates Carbapenem Resistance Through the NtrB/NtrC-OprD Regulatory Pathway in Pseudomonas aeruginosa. | Pathogens | 2026 | https://conductscience.org/library/papers/41901741 | PubMed |
| 41594104 | Natural and Synthetic Peptides as Alternatives to Antibiotics in Intestinal Infections-A Review. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/41594104 | PubMed |
| 41495674 | Genomic variants distinguish Pseudomonas aeruginosa from cystic fibrosis sputum and bloodstream infection. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/41495674 | PubMed |
| 41303349 | Protein-Protein Interactions as Promising Molecular Targets for Novel Antimicrobials Aimed at Gram-Negative Bacteria. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41303349 | PubMed |
| 41181323 | LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41181323 | PubMed |
Data2
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession | Source |
|---|---|---|
| BioProject | PRJNA527751 | BioProject |
| BioProject | PRJNA530912 | BioProject |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39711784
GET https://conductscience.org/api/papers/v1/39711784/references?page=2